Selected article for: "fusion protein and plasma membrane"

Author: Welch, Matthew D.
Title: Why should cell biologists study microbial pathogens?
  • Document date: 2015_12_1
  • ID: 04xyhhmf_7
    Snippet: Studying pathogens has also led to fundamental advances in the field of membrane trafficking. A classic example involves the extracellular bacterial pathogens C. botulinum, mentioned above, as well as Clostridium tetani, which causes the paralytic disease tetanus. In addition to the C3 exoenzyme, C. botulinum produces botulinum toxins A-G (type A is familiarly known as Botox), and C. tetani secretes tetanus toxin. These toxins specifically cleave.....
    Document: Studying pathogens has also led to fundamental advances in the field of membrane trafficking. A classic example involves the extracellular bacterial pathogens C. botulinum, mentioned above, as well as Clostridium tetani, which causes the paralytic disease tetanus. In addition to the C3 exoenzyme, C. botulinum produces botulinum toxins A-G (type A is familiarly known as Botox), and C. tetani secretes tetanus toxin. These toxins specifically cleave SNARE protein components of the vesicle fusion machinery, including VAMP, SNAP-25, and syntaxin (Link et al., 1992; Schiavo et al., 1992; Blasi et al., 1993a,b) . Microinjection of nerve cells with these toxins showed that SNARE molecules are critical for neurotransmitter release via vesicle fusion with the plasma membrane (Schiavo et al., 1992; Blasi et al., 1993b) . Preventing neurotransmitter release results in the paralysis caused by botulinum and tetanus toxins. In a contemporary study, it was revealed that SNARE proteins form a complex that is sufficient to mediate vesicle docking and fusion (Söllner et al., 1993) . Thus bacterial toxins were used in discovering fundamental mechanisms of membrane fusion and vesicular transport.

    Search related documents:
    Co phrase search for related documents
    • classic example and membrane trafficking: 1
    • Clostridium tetani and disease tetanus: 1
    • fusion machinery and membrane fusion: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • fusion vesicle docking and membrane fusion: 1
    • fusion vesicle docking and membrane trafficking: 1